FP7 and FP12, Two Synthetic Toll-like Receptor Antagonists, Do Not Cause Adverse Effects in Mice

Toll-like receptor 4 (TLR4) is a pattern-recognition receptor that detects lipopolysaccharides (LPSs) from Gram-negative bacteria, triggering innate immune and inflammatory responses. Research into TLR4 antagonists and agonists is crucial for developing novel therapies to modulate immune responses in infectious, inflammatory, and autoimmune diseases. Accordingly, some authors of this study developed synthetic TLR4 antagonists, including FP7 and FP12, and demonstrated their efficacy in inhibiting TLR4-mediated effects. This study specifically assesses the safety profile of these two novel TLR4 antagonists in mice following intraperitoneal administration. Clinical signs, body weights, and biochemical and haematological parameters in mice were assessed over four weeks after intraperitoneal administration of these molecules. No mortality or adverse effects were observed after administration of FP molecules. Key circulating biomarkers were also unaffected by these molecules. Preliminary LC–MS analysis detected both compounds in mouse plasma one hour after administration. Overall, this study demonstrates that FP7 and FP12 were well tolerated in mice, with no significant toxicological effects at the tested dose. These findings are an initial step toward further preclinical and clinical development of these molecules.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-13
DOI
https://doi.org/10.3390/ijms272210181
Primary Topic
Immune Response and Inflammation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

FP7 and FP12, Two Synthetic Toll-like Receptor Antagonists, Do Not Cause Adverse Effects in Mice

Alessio Romerio, Viridiana Alcántara‐Alonso, Ketan Patel, Nicholas Michael et al.
International Journal of Molecular Sciences
Immune Response and Inflammation
article

FP7 and FP12, Two Synthetic Toll-like Receptor Antagonists, Do Not Cause Adverse Effects in Mice

Alessio Romerio, Viridiana Alcántara‐Alonso, Ketan Patel, Nicholas Michael, Sakthivel Vaiyapuri, Francesco Peri, Grisha Pirianov, David S. Leake, Ali Alqallaf, Mohammed Monsoor Shaik, Andrew Parnell, Mustafa Jawad Jalil Al-Asady, Jomanah Alqallaf
article en

Abstract

Toll-like receptor 4 (TLR4) is a pattern-recognition receptor that detects lipopolysaccharides (LPSs) from Gram-negative bacteria, triggering innate immune and inflammatory responses. Research into TLR4 antagonists and agonists is crucial for developing novel therapies to modulate immune responses in infectious, inflammatory, and autoimmune diseases. Accordingly, some authors of this study developed synthetic TLR4 antagonists, including FP7 and FP12, and demonstrated their efficacy in inhibiting TLR4-mediated effects. This study specifically assesses the safety profile of these two novel TLR4 antagonists in mice following intraperitoneal administration. Clinical signs, body weights, and biochemical and haematological parameters in mice were assessed over four weeks after intraperitoneal administration of these molecules. No mortality or adverse effects were observed after administration of FP molecules. Key circulating biomarkers were also unaffected by these molecules. Preliminary LC–MS analysis detected both compounds in mouse plasma one hour after administration. Overall, this study demonstrates that FP7 and FP12 were well tolerated in mice, with no significant toxicological effects at the tested dose. These findings are an initial step toward further preclinical and clinical development of these molecules.

International Journal of Molecular SciencesVol. 27(22)
Anglia Ruskin University (GB), University of Milano-Bicocca (IT), University of Reading (GB)
Good health and well-being
Immune Response and Inflammation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon